Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Post by BornReady1970on May 07, 2009 12:41pm
360 Views
Post# 15974922

Market Valuation

Market ValuationISA sold 19% of the company for 11.35m this creates a market value of approximately 59m. Accounting for dilution the share price will trend up north of $0.40 over the next month. Yes there are other factors like the tax offsets carried forward and cost savings from having Palidin make the NDA application, etc. But the simple fact remains that the company has just been re-valued by the market in a big way and the share price will trend towards that valuation. 

cheers!

BR
Bullboard Posts